Imbio PHA (4.0.0) vs Withings Scan Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Imbio (a subsidiary of 4DMedical)
VS
by Withings

AI Verdict

Tool A is an AI-powered software designed for detailed cardiac structure measurement from CT pulmonary angiogram scans, primarily aiding in the diagnosis and risk stratification of conditions like pulmonary embolism and hypertension. Conversely, Tool B is a device-based AI solution integrated into smart scales and smartwatches, offering ECG for AFib detection, heart rate, and other vital health metrics for personal monitoring and remote patient care. While both leverage AI in cardiology and hold FDA clearance, they address distinct clinical workflows and utilize different data sources.

Choose Imbio PHA (4.0.0) if…

Choose Imbio PHA if your clinical practice requires automated, quantitative analysis of cardiac structures from CT pulmonary angiogram (CTPA) scans. This tool is ideal for radiologists and cardiologists needing rapid assessment of right ventricular dilation and accurate RV/LV and PA/Ao ratios to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. It seamlessly integrates into existing DICOM workflows to enhance diagnostic efficiency and precision.

View Imbio PHA (4.0.0) →

Choose Withings Scan Monitor if…

Choose Withings Scan Monitor if you are looking for a user-friendly, device-based solution for continuous personal health monitoring or remote patient management. This tool is perfectly suited for individuals and clinicians focused on proactive health tracking, including FDA-cleared ECG for AFib detection, heart rate monitoring, and other vital metrics like vascular age and body composition, all accessible via smart scales and smartwatches. It empowers patients to monitor their health at home and provides clinicians with valuable longitudinal data.

View Withings Scan Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Imbio PHA (4.0.0) Withings Scan Monitor
Pricing Unknown Device purchase with optional subscription for enhanced features and clinical services.
Deployment Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). Device-based (smart scale, smartwatch) with cloud synchronization and mobile application.
BAA Available Unknown Yes AI-estimated
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Withings Scan Monitor

Withings Scan Monitor, being device-based with a user-friendly mobile application and automatic synchronization, offers greater ease of use and accessibility for a broader range of users, including patients for remote monitoring. Imbio PHA, while efficient for clinical professionals, requires integration into complex hospital IT infrastructure, which can present a higher barrier to initial setup and daily interaction for non-specialized users.

Clinical Value

Imbio PHA (4.0.0)

Imbio PHA provides critical, quantitative diagnostic and risk stratification data from complex medical imaging (CTPA) for potentially life-threatening conditions such as pulmonary embolism and hypertension, directly informing specialist treatment decisions. While Withings Scan Monitor offers valuable continuous monitoring and early detection for common cardiovascular issues, its primary role is screening and monitoring, with definitive diagnosis and treatment still requiring further clinical evaluation.

Pricing & Value

Withings Scan Monitor

Withings Scan Monitor offers clear, transparent pricing for its devices and optional subscription services, allowing consumers and healthcare providers to easily understand the cost and assess its value proposition. Imbio PHA's 'contact for pricing' model, while typical for enterprise solutions, lacks the immediate transparency needed for a direct pricing and value comparison.

Enterprise Readiness

Imbio PHA (4.0.0)

Imbio PHA is clearly built for enterprise environments, offering flexible deployment options (cloud, on-premise, partners) and seamless integration with existing clinical DICOM tools and workflows. Its third-party HIPAA certification further underscores its readiness for secure, large-scale healthcare system adoption, unlike Tool B which is primarily a consumer device with remote monitoring capabilities.

Innovation

Withings Scan Monitor

Withings Scan Monitor demonstrates greater innovation by integrating sophisticated, FDA-cleared medical-grade diagnostics, such as 6-lead ECG and nerve health assessment, into accessible consumer devices like smart scales and smartwatches. This approach democratizes advanced health monitoring and pushes the boundaries of personal health technology. While Imbio PHA innovatively applies AI to automate complex medical image analysis, its innovation is more incremental within specialized clinical workflows.

Support & Docs

Withings Scan Monitor

Withings Scan Monitor offers a more comprehensive and readily accessible suite of support resources, including an extensive online knowledge base with detailed FAQs, tutorials, and troubleshooting guides, along with downloadable user manuals. This self-service approach, coupled with direct support contact, provides a superior user experience for its broad consumer and professional user base compared to Imbio PHA's more enterprise-focused support model where specific documentation often requires direct contact.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Imbio PHA (4.0.0) Withings Scan Monitor
Tool Name Imbio PHA (4.0.0) Withings Scan Monitor
Primary Use Case AI-powered medical image processing software for automatically measuring cardiac structures from CTPA scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. AI-powered tool integrated into smart scales and smartwatches, offering FDA-cleared ECG for AFib detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
Company Imbio Withings
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Pulmonology, Radiology Cardiology, Internal Medicine
Key AI-Powered Measurement/Detection Automated measurement of right and left ventricle diameters, automated measurement of main pulmonary artery and aorta diameters, calculates RV/LV and PA/Ao ratios. 6-lead ECG for Atrial Fibrillation (AFib) detection (Body Scan), Single-lead ECG for Atrial Fibrillation (AFib) detection (ScanWatch), Heart rate measurement, Vascular Age assessment (Body Scan), Nerve Health Score (Electrodermal Activity) (Body Scan).

Videos

Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Withings Scan Monitor.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Imbio PHA (4.0.0) is designed to automatically measure cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. Withings Scan Monitor, integrated into smart scales and smartwatches, offers FDA-cleared ECG for Atrial Fibrillation (AFib) detection, heart rate, and other vital health metrics for both personal use and professional remote patient monitoring.
Imbio PHA (4.0.0) specifically utilizes CT pulmonary angiogram (CTPA) scans for its analysis. Withings Scan Monitor gathers data directly from patients via device-based smart scales and smartwatches, including 6-lead or single-lead ECGs, heart rate, blood oxygen saturation, and other biometric measurements.
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows, providing rapid, automated assessment of CTPA scans and generating annotated DICOM images and summary reports in PDF format. Withings Scan Monitor operates through device-based smart scales and smartwatches with cloud synchronization and a mobile application, facilitating remote patient monitoring and data review by healthcare professionals.
Imbio PHA (4.0.0) provides automated measurements of right and left ventricle diameters, main pulmonary artery and aorta diameters, and calculates RV/LV and PA/Ao ratios. Withings Scan Monitor offers 6-lead ECG for AFib detection (Body Scan), single-lead ECG for AFib detection (ScanWatch), heart rate measurement, irregular rhythm notifications, blood oxygen saturation (SpO2), Vascular Age assessment, and Nerve Health Score.
Imbio PHA (4.0.0) is relevant to Cardiology, Pulmonology, and Radiology, focusing on diagnostic imaging analysis for conditions like pulmonary embolism and hypertension. Withings Scan Monitor is relevant to Cardiology and Internal Medicine, with a focus on remote patient monitoring and early detection of cardiac irregularities such as AFib.
AI Tool Finder
AI-powered search. Results may not be comprehensive.